Clinical Outcomes of Use of Olaparib in Castration Resistant Prostate Cancer

NCT06783127 · clinicaltrials.gov ↗

RECRUITING

Status

3000

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer
Castrate Resistant Prostate Cancer
BRCA Mutation

Interventions

DRUG: Olaparib

Sponsor

Santa Chiara Hospital